ReviewCurrent drug targets2024

Revolutionizing Skin Cancer Treatment: The Rise of PD-1/PDL-1 and CTLA-4 as Key Therapeutic Targets.

Neha Sharma et al.PubMed ↗Publisher ↗

No numbers read from the abstract.